{"schema_version":"secwatch.filing_event.v1","accession":"0001295947-26-000040","form_type":"8-K","ticker":"PBH","cik":"0001295947","company_name":"Prestige Consumer Healthcare Inc.","filed_at":"2026-08-06T10:04:34+00:00","discovered_at":"2026-08-06T10:10:00.467233+00:00","generated_at":"2026-08-06T10:11:03.390612+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Prestige Consumer Q1 revenue $265.7M (+6.5%), adj. EPS $0.98; raises FY outlook to $1.29-1.315B","bullets":["Q1 revenue $265.7M (+6.5% YoY); organic sales growth 3.2% exceeded expectations.","GAAP diluted EPS $0.61; adjusted diluted EPS $0.98 vs $0.95 prior year.","Closed Breathe Right acquisition (June) and LaCorium (July); added $6M revenue in Q1.","Raised FY2027 outlook: revenue $1,290-$1,315M, adj. EPS $4.55-$4.65 (from $4.42-$4.51).","Issued $400M 6.25% senior notes due 2034, extending nearest maturity to 2031."],"urls":{"canonical":"https://secwatch.observer/filing/0001295947-26-000040","json":"https://secwatch.observer/filing/0001295947-26-000040.json","markdown":"https://secwatch.observer/filing/0001295947-26-000040.md","text":"https://secwatch.observer/filing/0001295947-26-000040.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1295947/000129594726000040/0001295947-26-000040-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1295947/000129594726000040/pbh-20260806.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-06T10:11:03.390612+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}